Mehtap Çakır

Prof. Mehtap Çakır is a seasoned endocrinologist with a strong clinical and academic background. She completed her specialist training in Endocrinology and Metabolic Diseases at Akdeniz University Faculty of Medicine in 2003. Currently affiliated with Acıbadem Health Group since 2023, she combines patient care with active involvement in research and scholarly work. She serves on the editorial board of the European Thyroid Journal, the official publication of the European Thyroid Association (since 2023), and on the editorial board of Endocrinology Research and Clinical Practice, the official journal of the Turkish Society of Endocrinology and Metabolism (since 2022). Her professional memberships include the European Society of Endocrinology (since 2007), the American Endocrine Society (since 2007), the European Thyroid Association (since 2008), and the Turkish Society of Endocrinology and Metabolism (since 2000). Prof. Çakır’s work focuses on endocrine disorders, with particular interest in thyroid disease and metabolic conditions. She is committed to advancing clinical practice through research, education, and active participation in international and national endocrine societies.

Education

• 2003 Akdeniz University Faculty of Medicine Endocrinology and Metabolic Diseases
• 1999 Ankara University Faculty of Medicine Internal Medicine
• 1993 Hacettepe University Faculty of Medicine

Experience

• 2023 Acibadem Health Group
• 2012 – 2022 Private Kent Hospital
• 2020 Acibadem Health Group
• 2008 – 2012 Konya Selcuk University Faculty of Medicine, Endocrinology and Metabolic Diseases
• 2007 – 2008 St. Bart’s and the London, School of Medicine and Dentistry, Dept. Of Endocrinology, Honorary Research Fellow, London, England
• 2005 – 2007 Konya Selcuk University Faculty of Medicine, Endocrinology and Metabolic Diseases
• 2000 – 2003 Akdeniz University Faculty of Medicine / Dr. Research Assistant
• 1994 – 1999 Ankara University Faculty of Medicine / Research Assistant
• 1993 – 1994 Ministry of Health Ankara Hospital / Research Assistant

Memberships

• European Thyroid Journal Editorial Board (Official publication of the European Thyroid Association, 2023 – )
• Editorial Board of Endocrinology Research and Clinical Practice (Official publication of the Turkish Society of Endocrinology and Metabolism, 2022 – )
• European Society of Endocrinology (2007 – )
• Turkish Society of Endocrinology and Metabolism (2000 – )
• American Endocrine Society (2007 – )
• European Thyroid Association (2008 – )

Publications

• Comparison of cardiac arrhythmia types between hyperthyroid patients with Graves? disease and toxic nodular goiter.
  Turan E, Can I, Turan Y, Uyar M, Cakir M. Acta Endocrinologica 2018;14:324-329.
• The effect of hypothyroidism on color contrast sensitivity: A prospective study.
  Eur Thyroid J 2015;4:43-47. Cakir M, Ozturk BT, Turan E, Gonulalan G, Polat I, Gunduz K.
• Radiotherapy-induced hypopituitarism in nasopharyngeal carcinoma: the tip of an iceberg.
  Exp Clin Endocrinol Diab 2015;123:411-418. İpekci SH, Cakir M, Kıyıcı A, Koc A, Artac M.
• Serum CXCL10 levels and neuromuscular manifestations in patients with autoimmune thyroid diseases.
  Autoimmunity 2011;44:496-503. Cakir M, Levendoglu F, Kiyici A, Coskun Y.
• The molecular pathogenesis and management of bronchial carcinoids.
  Expert Opin Ther Targets 2011;15:457-491. Cakir M, Grossman AB.
• Somatostatin receptor biology in neuroendocrine and pituitary tumors: part 1: molecular pathways.
  J Cell Mol Med 2010;14:2570-2584. Cakir M, Dworakowska D, Grossman AB
• Somatostatin receptor biology in neuroendocrine and pituitary tumors: part 2: clinical implications.
  J Cell Mol Med 2010;14:2585-2591. Cakir M, Dworakowska D, Grossman AB.
• Differential Diagnosis of Hyperthyroidism. Endocrinology Research and Clinical Developments Series.
  Nova Science Publishers Inc., New York, 2010. Cakir M.
• Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis.
  Expert Opin Ther Targets 2009;13:1121-1134. Cakir M, Grossman AB.
• Incidental thyroid carcinoma in thyrotoxic patients treated by surgery.
  Horm Res 2007;67:96-99. Cakir M, Arici C, Alakus H, Altunbas H, Balci MK, Karayalcin U.